Key terms

About LQDA

Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. The company was founded on June 28, 2020, and is headquartered in Morrisville, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LQDA news

Apr 30 9:32am ET Analysts’ Top Healthcare Picks: Qiagen (QGEN), Eli Lilly & Co (LLY) Apr 02 5:11am ET Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT) Apr 01 10:35am ET Buy Rating Justified by Favorable Legal Outcomes and Imminent FDA Decision for Liquidia Technologies’ Yutrepia Apr 01 6:11am ET Liquidia provides YUTREPIA regulatory update Mar 15 11:32am ET Biotech Alert: Searches spiking for these stocks today Mar 14 10:25am ET Liquidia Technologies Faces Sell Rating Amid Legal Struggles and Market Competition Mar 14 6:26am ET Buy Rating Affirmed for Liquidia Technologies with Doubling Price Target on Yutrepia’s Promising Prospects Mar 14 6:10am ET Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA) and Legend Biotech (LEGN) Mar 14 5:47am ET Strong Growth Prospects for Liquidia Technologies with Impending Approvals and Robust Product Pipeline Mar 13 2:55pm ET Buy Rating Affirmed for Liquidia Technologies Amid Favorable Legal Rulings and Yutrepia’s Market Potential Feb 21 1:15pm ET Buy Rating Affirmed for Liquidia Technologies Amidst Strong Market Growth and Favorable Regulatory Outlook Feb 21 6:07am ET United Therapeutics commences litigation with FDA on drug review process Feb 12 4:36am ET United Therapeutics upgraded to Neutral from Sell at Goldman Sachs Feb 07 12:05pm ET Liquidia Technologies call volume above normal and directionally bullish

No recent press releases are available for LQDA

LQDA Financials

1-year income & revenue

Key terms

LQDA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LQDA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms